JP2002517755A - 子癇前症の予想テスト - Google Patents

子癇前症の予想テスト

Info

Publication number
JP2002517755A
JP2002517755A JP2000553804A JP2000553804A JP2002517755A JP 2002517755 A JP2002517755 A JP 2002517755A JP 2000553804 A JP2000553804 A JP 2000553804A JP 2000553804 A JP2000553804 A JP 2000553804A JP 2002517755 A JP2002517755 A JP 2002517755A
Authority
JP
Japan
Prior art keywords
free
risk
sample
levels
eclampsia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000553804A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002517755A5 (enExample
Inventor
ジョン ウォールド ニコラス
レッドマン クリストファー
Original Assignee
クイーンメリー アンド ウエストフィールド カレッジ
ユニバーシティ オブ オックスフォード
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by クイーンメリー アンド ウエストフィールド カレッジ, ユニバーシティ オブ オックスフォード filed Critical クイーンメリー アンド ウエストフィールド カレッジ
Publication of JP2002517755A publication Critical patent/JP2002517755A/ja
Publication of JP2002517755A5 publication Critical patent/JP2002517755A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2000553804A 1998-06-09 1999-06-09 子癇前症の予想テスト Pending JP2002517755A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9812432.4 1998-06-09
GBGB9812432.4A GB9812432D0 (en) 1998-06-09 1998-06-09 Predictive test
PCT/GB1999/001828 WO1999064860A2 (en) 1998-06-09 1999-06-09 Predictive test for pre-eclampsia

Publications (2)

Publication Number Publication Date
JP2002517755A true JP2002517755A (ja) 2002-06-18
JP2002517755A5 JP2002517755A5 (enExample) 2006-08-31

Family

ID=10833482

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000553804A Pending JP2002517755A (ja) 1998-06-09 1999-06-09 子癇前症の予想テスト

Country Status (7)

Country Link
US (1) US6735529B1 (enExample)
EP (1) EP1084412A2 (enExample)
JP (1) JP2002517755A (enExample)
AU (1) AU751415B2 (enExample)
CA (1) CA2332349A1 (enExample)
GB (1) GB9812432D0 (enExample)
WO (1) WO1999064860A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072208A2 (en) * 2000-03-29 2001-10-04 University Of Virginia Patent Foundation Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
RU2243562C1 (ru) * 2003-07-04 2004-12-27 Новокузнецкий государственный институт усовершенствования врачей Способ прогнозирования риска развития эклампсии у беременных
US20050196812A1 (en) * 2004-03-05 2005-09-08 Williams David E. Determining the estimated date of embryo implantation and related dates
EP1571451A1 (en) * 2004-03-05 2005-09-07 Inverness Medical Switzerland GmbH Method and apparatus for estimating due date
US20100190192A1 (en) * 2005-09-15 2010-07-29 Victor Voroteliak Method of diagnosing pre-eclampsia
ES2523220T3 (es) 2008-01-25 2014-11-24 Perkinelmer Health Sciences, Inc. Métodos para determinar el riesgo de complicaciones prenatales
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
US10670610B2 (en) 2012-06-15 2020-06-02 Wayne State University Biomarker test for prediction or early detection of preeclampsia and/or HELLP syndrome
CN106796241B (zh) 2014-09-02 2019-07-12 沃拉克有限公司 确定先兆子痫风险的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007122A1 (en) * 1988-12-14 1990-06-28 The Regents Of The University Of California Diagnostic assay for the detection of preeclampsia
US5712103A (en) 1995-02-13 1998-01-27 Regents Of The University Of California Diagnostic assay for the prediction of preeclampsia
GB9614615D0 (en) * 1996-07-11 1996-09-04 Isis Innovation Diagnosis of pre-eclampsia
CA2275708A1 (en) * 1996-12-23 1998-07-02 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies

Also Published As

Publication number Publication date
AU4280299A (en) 1999-12-30
WO1999064860A3 (en) 2000-03-02
CA2332349A1 (en) 1999-12-16
WO1999064860A2 (en) 1999-12-16
US6735529B1 (en) 2004-05-11
GB9812432D0 (en) 1998-08-05
EP1084412A2 (en) 2001-03-21
AU751415B2 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
Krantz et al. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency
Jaslow et al. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses
Santoro et al. Assessing menstrual cycles with urinary hormone assays
AU763171B2 (en) Antenatal screening for Down's Syndrome
Silver et al. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies
Yefet et al. Predictive value of second-trimester biomarkers and maternal features for adverse pregnancy outcomes
US6010912A (en) Antenatal screening for chromosomal abnormalities
WO2005037059A2 (en) Multi-marker screening protocol for fetal abnormalities
Wald et al. Advances in antenatal screening for Down syndrome
JP2002517755A (ja) 子癇前症の予想テスト
AU2009273771A1 (en) Methods and kits for predicting the onset of labour
Kirkegaard et al. PAPP‐A, free β‐hCG, and early fetal growth identify two pathways leading to preterm delivery
Palomaki et al. A summary analysis of Down syndrome markers in the late first trimester
Ross et al. Maternal serum screening for fetal genetic disorders
Markestad et al. Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol.
JPH09113508A (ja) 妊娠異常について妊娠期間中にスクリーニングするための方法および装置
Kellner et al. Levels of urinary beta‐core fragment, total oestriol, and the ratio of the two in second‐trimester screening for Down syndrome
Ashwal et al. Comparison of circulating maternal placenta growth factor levels and sonographic evaluation of patients with abnormal first trimester screening analytes
EP0617921B1 (en) Antenatal screening for chromosomal abnormalities
Lambert‐Messerlian et al. Early onset preeclampsia and second trimester serum markers
Rahim et al. Compromise ultrasound dating policy in maternal serum screening for Down syndrome
US5906944A (en) Prenatal screening for fetal abnormalities
Baliff et al. New developments in prenatal screening for Down syndrome
MacRae et al. Second and first trimester estimation of risk for Down syndrome: implementation and performance in the SAFER study
Pedersen et al. Pregnancy-associated plasma protein A in first trimester of diabetic pregnancy and subsequent fetal growth

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060301

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20060301

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060609

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060627

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061218

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080718

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080808

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080718

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080808

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090217

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090427

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090930